BIOMAT Database Logo BIOMAT Database Logo

Is herpes simplex virus type 1 (HSV-1) now more common than HSV-2 in first episodes of genital herpes? 2003

Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry

UI MeSH Term Description Entries
D006558 Herpes Genitalis Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females. Genital Herpes,Herpes Simplex, Genital,Herpes Simplex Virus Genital Infection,Genital Herpes Simplex,Herpes, Genital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012725 Sexual Behavior Sexual activities of humans. Anal Sex,Oral Sex,Sexual Activity,Sexual Orientation,Premarital Sex Behavior,Sex Behavior,Sex Orientation,Sexual Activities,Activities, Sexual,Activity, Sexual,Behavior, Premarital Sex,Behavior, Sex,Behavior, Sexual,Orientation, Sexual,Sex, Anal,Sex, Oral
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.
D018258 Herpesvirus 2, Human A species of SIMPLEXVIRUS associated with genital infections (HERPES GENITALIS). It is transmitted by sexual intercourse and close personal contact. HSV-2,Herpes Simplex Virus 2,Human Herpesvirus 2,HHV-2,Herpes Simplex Virus Type 2,Herpesvirus 2 (alpha), Human
D018259 Herpesvirus 1, Human The type species of SIMPLEXVIRUS causing most forms of non-genital herpes simplex in humans. Primary infection occurs mainly in infants and young children and then the virus becomes latent in the dorsal root ganglion. It then is periodically reactivated throughout life causing mostly benign conditions. HSV-1,Herpes Simplex Virus 1,HHV-1,Herpes Simplex Virus Type 1,Herpesvirus 1 (alpha), Human,Human Herpesvirus 1
D022301 Herpes Simplex Virus Vaccines Vaccines or candidate vaccines used to prevent infection with viruses from the genus SIMPLEXVIRUS. This includes vaccines for HSV-1 and HSV-2. HSV Vaccines,Simplexvirus Vaccines,Vaccines, HSV,Vaccines, Simplexvirus

Related Publications

Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1.
August 2020, Vaccines,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes.
January 2006, Acta dermato-venereologica,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates.
January 2002, Acta dermato-venereologica,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Application of shRNA-containing herpes simplex virus type 1 (HSV-1)-based gene therapy for HSV-2-induced genital herpes.
November 2013, Journal of virological methods,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
[Herpes simplex virus type 1 and 2 (HSV-1,2) DNA detection by PCR during genital herpes].
January 2006, Molekuliarnaia genetika, mikrobiologiia i virusologiia,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Genotypic analysis of sequential genital herpes simplex virus type 1 (HSV-1) isolates of patients with recurrent HSV-1 associated genital herpes.
August 2004, Journal of medical virology,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
July 2007, AIDS (London, England),
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.
February 2003, The Journal of infectious diseases,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2.
April 2003, Sexually transmitted diseases,
Gregory J Mertz, and Susan L Rosenthal, and Lawrence R Stanberry
Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.
March 2016, International journal of STD & AIDS,
Copied contents to your clipboard!